Menu Back toSession-12-Track-B-TBD

Advertising and Promotion Regulatory Affairs Conference


Session 12: FDA’s Guidance on Electronic Submissions of Promotional Materials

    Session Chair(s)
      Jason  Cober

      Jason Cober

      • Lead Project Manager, OPDP
      • FDA, United States
    Join members of FDA’s Office of Prescription Drug Promotion (OPDP) and an industry representative as they provide in-depth insight and advice regarding the submission of promotional materials in electronic Common Technical Document (eCTD) format to OPDP. FDA will provide a brief overview of the Providing Regulatory Submissions in Electronic and Non-Electronic Format—Promotional Labeling and Advertising Materials for Human Prescription Drugs draft guidance, review selected portions of the guidance in detail, and provide helpful technical tips for successfully submitting promotional materials to FDA as described in the guidance. An example of how one firm transitioned to eCTD will be shared. The presentation will wrap-up with a brief Q&A session.
    Learning Objective :
    • Recognize the binding requirements and non-binding recommendations included in the FDA’s Guidance on Electronic Submissions of Promotional Materials
    • Utilize recommended best practices based on FDA’s experience since the publication of OPDP’s Draft Electronic Submissions Guidance
    • Describe company best practices for conversion to eCTD for Promotional Submissions
    Speaker(s)
      Jason  Cober

      Panelist

      Jason Cober

      • Lead Project Manager, OPDP
      • FDA, United States
      Josephine  Secnik, MBA, MS

      Panelist

      Josephine Secnik, MBA, MS

      • Director – Ad/Promo Regulatory Affairs
      • Eli Lilly and Company, United States
      KEMI  ASANTE, PharmD, MPH, RAC

      Panelist

      KEMI ASANTE, PharmD, MPH, RAC

      • POLICY ANALYST
      • FDA, United States

Contact us